News

NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)


 

References

The leading rare disease patient organizations in the US and Europe—NORD and EURORDIS—together with rare disease umbrella organizations from 30 nations around the world have launched a new global alliance to be known as Rare Diseases International. The collaboration was announced May 28th at a meeting in Madrid. NORD will be the US representative in this alliance, which also adopted a joint declaration for rare diseases to be an international public health priority. Read the press release.

Recommended Reading

Conference News Update—Federation of American Societies for Experimental Biology
MDedge Neurology
NORD to honor NIH Director and others at Portraits of Courage Celebration
MDedge Neurology
NORD urges Congress to support development of treatments for rare pediatric diseases
MDedge Neurology
ACMG and GMDI develop first guidelines for medical and dietary treatment of PKU
MDedge Neurology
Neurologists describe how “cyberconsults” may help those training for rare disease careers
MDedge Neurology
Genetic testing improves diagnostic yield in children with encephalopathy
MDedge Neurology
AAN and AANEM publish guides for evaluation, diagnosis and management of Congenital Muscular Dystrophy (CMD)
MDedge Neurology
AAN: Largest neuroleptic malignant syndrome study finds predictors of poor outcome
MDedge Neurology
A New Symptomatic Treatment for Lambert-Eaton Myasthenic Syndrome?
MDedge Neurology
Research Illuminates Genetic Forms of Epilepsy
MDedge Neurology